---
title: "Shree Ganesh Biotech India Ltd (539470) — Share Price, Financials & Analysis"
symbol: "539470"
company: "Shree Ganesh Biotech India Ltd"
canonical: "https://tapetide.com/stocks/539470"
isin: "INE051N01026"
nse_symbol: "SHREEGANESHBIOTECHINDIALTD"
bse_code: "539470"
sector: "Healthcare"
industry: "Biotechnology"
market_cap_cr: 19.5
generated_at: "2026-09-13T18:26:54.239Z"
---

# Shree Ganesh Biotech India Ltd (539470)

Canonical page: https://tapetide.com/stocks/539470

## Company

- **NSE Symbol:** SHREEGANESHBIOTECHINDIALTD
- **BSE Code:** 539470
- **ISIN:** INE051N01026
- **Sector:** Healthcare
- **Industry:** Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2017-09-22
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** shreeganeshbiotech.club

## About

Incorporated in 1982, Shree Ganesh Biotech Ltd is engaged in the trading of seeds and bhushi.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:37:05.194135Z.

- **Market Cap:** ₹19.5 Cr
- **Classification:** Microcap
- **P/E (reported):** -49
- **EPS (TTM):** ₹0
- **EPS (reported):** ₹0.02
- **Book Value:** ₹1.6
- **Price to Book:** 0.31
- **Dividend Yield:** 0%
- **ROE:** 0.59%
- **ROCE:** 0.81%
- **Debt to Equity:** 0
- **Revenue (yearly):** ₹6.4 Cr
- **Net Income:** ₹0.4 Cr
- **EBITDA:** ₹0.5 Cr
- **52-Week High:** ₹0.8
- **52-Week Low:** ₹0.48
- **RSI (14):** 43.26

## Tapetide Score

- **Score:** 38 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 10.2 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 63.86 | 9% |
| growth | 1.1 | 9% |
| momentum | 22.04 | 12% |
| ownership | 50 | 24% |
| quality | 28.21 | 22% |
| valuation | 44.81 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is almost debt free.
- Stock is trading at 0.31 times its book value

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -22.0% over past five years.
- Company has a low return on equity of 0.84% over last 3 years.
- Working capital days have increased from 260 days to 861 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 19.69% | -180.71% | -329.69% |
| ebitda margin growth | -200% | 402.52% | 99.25% | 66.11% |
| net income growth | -200% | 33.33% | -33% | 3% |
| revenue growth | -25% | -73.77% | -57% | -22% |
| roce | — | 32.79% | -40.44% | 2.59% |
| roe | — | 34.09% | 0.67% | -85.92% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 4.12 | 4.12 | 3.78 | 3.56 | 1.98 | 14.41 | 3.01 | 1.38 | 0.77 | 0.7 | 2.12 | 1.43 |
| Expenses | 4.04 | 4.03 | 4.3 | 3.69 | 1.96 | 13.94 | 4.43 | 1.47 | 1.17 | 0.75 | 2.55 | 2.32 |
| Operating Profit | 0.08 | 0.09 | -0.52 | -0.13 | 0.02 | 0.47 | -1.42 | -0.09 | -0.4 | -0.05 | -0.43 | -0.89 |
| OPM % | 1.94 | 2.18 | -13.76 | -3.65 | 1.01 | 3.26 | -47.18 | -6.52 | -51.95 | -7.14 | -20.28 | -62.24 |
| Other Income | 0 | 0 | 1.06 | 0.37 | 0.3 | 0.3 | 0.47 | 0.42 | 0.41 | 0.37 | 0.28 | 0.32 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.08 | 0.09 | 0.54 | 0.24 | 0.32 | 0.77 | -0.95 | 0.33 | 0.01 | 0.32 | -0.15 | -0.57 |
| Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0.08 | 0.09 | 0.54 | 0.24 | 0.32 | 0.77 | -0.95 | 0.33 | 0.01 | 0.32 | -0.15 | -0.57 |
| EPS in Rs | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.02 | -0.02 | 0.01 | 0 | 0.01 | 0 | -0.01 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 7.86 | 5.87 | 2.47 | 17.21 | 72.64 | 62.45 | 20.28 | 22.96 | 4.97 | 5.02 |
| Expenses | 4.36 | 4.08 | 2.23 | 16.5 | 69.19 | 60.3 | 20.48 | 23.92 | 5.61 | 6.79 |
| Operating Profit | 3.5 | 1.79 | 0.24 | 0.71 | 3.45 | 2.15 | -0.2 | -0.96 | -0.64 | -1.77 |
| OPM % | 44.53 | 30.49 | 9.72 | 4.13 | 4.75 | 3.44 | -0.99 | -4.18 | -12.88 | -35.26 |
| Other Income | 0 | 0 | 0 | -0.28 | 0.05 | 0.56 | 1.06 | 1.35 | 1.15 | 1.38 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 3.5 | 1.79 | 0.24 | 0.43 | 3.5 | 2.71 | 0.86 | 0.39 | 0.51 | -0.39 |
| Tax % | 0 | 0 | 0 | 25.58 | 27.71 | 25.09 | 26.74 | 28.21 | 27.45 | — |
| Net Profit | 3.5 | 1.79 | 0.24 | 0.32 | 2.53 | 2.04 | 0.62 | 0.28 | 0.38 | -0.39 |
| EPS in Rs | 0.95 | 0.04 | 0.01 | 0.01 | 0.06 | 0.05 | 0.02 | 0.01 | 0.01 | 0 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 1.83 | 1.83 | 19.93 | 19.93 | 19.93 | 19.93 | 39.86 | 39.86 | 39.86 | 39.86 |
| Reserves | 17.54 | 21.04 | 37.31 | 37.54 | 37.86 | 40.39 | 22.49 | 23.12 | 23.39 | 23.77 |
| Borrowings | 0.06 | 0.19 | 0.19 | 0.19 | 0.19 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 0.01 | 3.3 | 6.66 | 7.06 | 16.64 | 33.24 | 17.18 | 10.64 | 0.24 | 0.17 |
| Total Liabilities | 19.44 | 26.36 | 64.09 | 64.72 | 74.62 | 93.56 | 79.53 | 73.62 | 63.49 | 63.8 |
| Fixed Assets | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 3.06 | 3.22 | 0 | 0 | 9.15 | 9.15 |
| Other Assets | 19.44 | 26.36 | 64.08 | 64.72 | 71.56 | 90.34 | 79.53 | 73.62 | 54.34 | 54.65 |
| Total Assets | 19.44 | 26.36 | 64.09 | 64.72 | 74.62 | 93.56 | 79.53 | 73.62 | 63.49 | 63.8 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -12.94 | 2.23 | -0.5 | -1.01 | 2.36 | 3.57 | 10.54 | 10.16 | -10.21 | -8.2 |
| Cash from Investing Activity | 2.53 | -2.36 | -32.07 | 0.99 | -2.36 | -3.37 | -10.09 | -10.21 | 9.8 | 8.19 |
| Cash from Financing Activity | 10.42 | 0.13 | 32.58 | 0 | 0 | -0.19 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0.02 | 0 | 0.01 | -0.02 | 0.01 | 0.01 | 0.44 | -0.05 | -0.41 | 0 |
| Free Cash Flow | -10.62 | 2.23 | -0.51 | -1.01 | 2.36 | 3.57 | 10.54 | 10.16 | -10.21 | -8.2 |
| CFO/OP | -344 | 64 | -28 | -421 | 348 | 132 | 522 | -5080 | 1052 | 1259 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 384.23 | 627.84 | 1191.38 | 3072.21 | 601.05 | 220.54 | 112.98 | 59.39 | 0 | 0 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 46.59 | 846.14 |
| Days Payable | — | — | — | — | — | — | — | — | 0 | 0 |
| Cash Conversion Cycle | 384.23 | 627.84 | 1191.38 | 3072.21 | 601.05 | 220.54 | 112.98 | 59.39 | 46.59 | 846.14 |
| Working Capital Days | 383.81 | 475.99 | 779.12 | 2036.32 | 249.2 | 53.71 | 12.8 | -132.11 | 50.08 | 860.72 |
| ROCE % | 30.45 | 16.47 | 4.45 | 0.42 | 1.23 | 5.92 | 4.42 | 1.37 | 0.76 | 1.31 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| FIIs | 2.17% | 2.17% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% | 1.42% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 81.44% | 93.18% | 94.65% | 95.39% | 95.31% | 95.29% | 95.24% | 95.3% | 95.27% | 95.4% | 95.33% | 95.36% |
| Others | 16.39% | 4.65% | 3.93% | 3.19% | 3.27% | 3.29% | 3.34% | 3.28% | 3.31% | 3.18% | 3.25% | 3.22% |
| No. of Shareholders | 78096 | 139880 | 176722 | 181198 | 185335 | 192040 | 195435 | 192235 | 189375 | 186148 | 183658 | 181722 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 1 / 6 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 0.5 | Sell |
| EMA (10) | 0.5 | Sell |
| SMA (20) | 0.5 | Sell |
| EMA (20) | 0.5 | Sell |
| SMA (50) | 0.53 | Sell |
| EMA (50) | 0.53 | Sell |
| SMA (100) | 0.56 | Sell |
| EMA (100) | 0.56 | Sell |
| SMA (200) | 0.59 | Sell |
| EMA (200) | 0.61 | Sell |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 39.12 | Neutral |
| MACD (12,26,9) | -0.01 | Sell |
| Stochastic (14,3,3) | 33.33 | Neutral |
| ADX (14) | 48.73 | Buy |
| Williams %R (14) | -75 | Neutral |
| ATR (14) | 0.02 | High Volatility |
| ROC (12) | -3.92 | Sell |
| Stoch RSI (14) | 55.17 | Neutral |
| UO (7,14,28) | 48.89 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-03 | [Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee0aef0a-8057-4850-8cd5-b51484231926.pdf) |
| 2026-09-03 | [Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=01b2c247-0591-4741-a8aa-c7b8291c2d11.pdf) |
| 2026-09-03 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=91aabaeb-0459-4ada-b993-b737267b200f.pdf) |
| 2026-09-01 | [Updation In The Website Of The Company](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d0d86a6-cdc1-4ff9-9d23-330fea563eac.pdf) |
| 2026-08-04 | [Board Meeting Outcome for Outcome Of Board Meeting Held On 4Th August 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b83bde8f-c62d-4c3a-b235-dfaa17eaa52d.pdf) |
| 2026-08-04 | [Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=90b16926-1dd6-454b-9381-1572bb8fa843.pdf) |
| 2026-07-21 | [Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ab39b034-e5f0-4a14-8893-959d4e0d4f17.pdf) |
| 2026-07-07 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4301d486-ee7e-42f9-8212-8ad1dbcae04a.pdf) |
| 2026-06-12 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b861e9ef-b0b1-4735-826c-786cb6cde3b8.pdf) |
| 2026-05-23 | [Compliances-Reg.24(A)-Annual Secretarial Compliance](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=008e1af0-783a-4493-8b29-7229c744436d.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-04 | [Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b33bfb1f-f272-4f0c-abc5-5a60e5f18021.pdf) |
| 2026-05-14 | [Regulation 33 Read With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations")](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=57d132d5-cc18-4430-945d-19786bc7fb93.pdf) |
| 2026-01-29 | [Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6610cd6e-3624-4828-8354-9fba551baaee.pdf) |
| 2025-11-08 | [Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51797923-828e-4893-ab6c-53bed4ca748d.pdf) |
| 2025-07-25 | [Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f61dc837-889e-4ad2-ba34-cb1b32b37ef4.pdf) |
| 2025-05-22 | [Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=36295729-3648-4f41-a241-e2dcbcf3a1c6.pdf) |
| 2025-02-04 | [Pursuant To Second Proviso To Regulation 30(6) And Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 We Hereby Inform You That The Board Of Directors Of The](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=70576c8a-45e4-4116-bbc7-aee858f1116f.pdf) |
| 2024-10-23 | [Regulations 30, 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=93a6e548-9d0d-4c5c-b136-eab9e2924310.pdf) |
| 2024-08-13 | [Un-Audited Financial Result Quarter Ending 30Th June, 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015<BR> <BR>](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3252fdd3-9225-4c6c-956a-d98acf1d9f11.pdf) |
| 2024-08-13 | [Un-Audited Financial Result Quarter Ending 30Th June, 2024 Pursuant To Regulation 33 Of The SEBI (LODR) Regulations, 2015<BR> <BR>](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7c9e6b84-1bd4-4ab2-ba8d-e857166754a2.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9h - Company not a large corporate; no debt disclosure required for FY ended March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 9h - Company not a large corporate; no debt disclosure required for FY ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/de832724-1129-4b19-aed7-97195088dca4.pdf) |
| 6 Feb - Board meeting Feb 14, 2026 to approve unaudited results for nine months ended 31-Dec-2025; trading window reopens Feb 17. | [Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter Ended 31St December, 2025. 6 Feb - Board meeting Feb 14, 2026 to approve unaudited results for nine months ended 31-Dec-2025; trading window reopens Feb 17.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/244b555b-0992-4906-8876-18df8dea266f.pdf) |
| 5 Jan - RTA certificate for quarter ended 31 Dec 2025; no physical demat requests. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 5 Jan - RTA certificate for quarter ended 31 Dec 2025; no physical demat requests.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d8785872-d811-42c4-a4a2-93e2efb11a07.pdf) |
| 4 May - Board meeting on 14 May 2026 to approve audited standalone results for year ended 31 March 2026. | [Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting. 4 May - Board meeting on 14 May 2026 to approve audited standalone results for year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bf806236-72fe-460a-95a9-e708c96821dd.pdf) |
| 4 May - Board meeting on 14 May 2026 to approve audited standalone results for year ended 31 March 2026. | [Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations, 2015 - Intimation Of Board Meeting. 4 May - Board meeting on 14 May 2026 to approve audited standalone results for year ended 31 March 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/bf806236-72fe-460a-95a9-e708c96821dd.pdf) |
| 29 Jan - No unutilised proceeds from past public/right/preferential/QIP issues as of 31 Dec 2025. | [Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 29 Jan - No unutilised proceeds from past public/right/preferential/QIP issues as of 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c8814dd3-83c9-4ee2-8275-0032d30f727c.pdf) |
| 29 Jan - Board approved unaudited Q3/9M results to 31-Dec-2025: total income ₹106.90L, profit ₹32.23L. | [Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 29Th January 2026. 29 Jan - Board approved unaudited Q3/9M results to 31-Dec-2025: total income ₹106.90L, profit ₹32.23L.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/26e144a9-1a8e-4368-a470-b3dcae6f68f1.pdf) |
| 29 Jan - Approved unaudited Q3 and nine-month results to Dec 31, 2025; Q3 PAT ₹32.23 lakh, 9M PAT ₹66.34 lakh. | [Regulations 30, 33 And Other Applicable Provisions Of The SEBI (LODR) Regulations, 2015 29 Jan - Approved unaudited Q3 and nine-month results to Dec 31, 2025; Q3 PAT ₹32.23 lakh, 9M PAT ₹66.34 lakh.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6610cd6e-3624-4828-8354-9fba551baaee.pdf) |
| 25 Feb - Investors Presentation of the Company. The presentation is also being made available on the Company''s Website www.veerhealthcare.net. | [Announcement under Regulation 30 (LODR)-Investor Presentation 25 Feb - Investors Presentation of the Company. The presentation is also being made available on the Company''s Website www.veerhealthcare.net.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/90a49d03-09f6-4106-b079-acfb3c34426d.pdf) |
| 25 Feb - Investors Presentation of the Company. The presentation is also being made available on the Company''s Website www.veerhealthcare.net. | [Announcement under Regulation 30 (LODR)-Investor Presentation 25 Feb - Investors Presentation of the Company. The presentation is also being made available on the Company''s Website www.veerhealthcare.net.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0becb894-624a-4ae8-ae3d-29ace1624e87.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Sep 2024 | [Concall - Sep 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c992a66c-789f-4909-8ad7-c30f0c647db6.pdf) |
| Jun 2024 | [Concall - Jun 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c57da3f1-7097-4122-9810-09998f393885.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a2a91639-6ee6-478d-bbff-75cdf1004972.pdf) |
| Aug 2025 | [Concall - Aug 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e14f1798-bee5-4bed-8a61-9a8a6b912b6c.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c6d8a005-9ebc-4234-82c8-8de92c40973e.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5cd6c928-9a67-407d-a1b3-b3b6719427bb.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/436f7933-e24b-4372-989b-b97f25abda5e.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9ceb6726-1744-4944-a392-0a097873e657.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f4e314af-0704-4eff-a578-4f3eaec5ba34.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/83c138d8-2bdb-49ef-949f-79a22ae5c384.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/511523/74851511523.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/539470/76219539470.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/511523/70139511523.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/539470/69941539470.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:54.239Z.